About this trial
During surgery that is done using a robot, the surgeon needs to put carbon dioxide gas into the belly to lift the belly wall. This is done so the surgeon can adequately see all the body organs and operate safely. Many surgeons currently use a standard pressure of 15 mmHg (a unit to measure pressure). However, many patients find the use of this pressure to be painful after surgery. New research has shown that using a lower pressure with a device called "AirSeal" can safely reduce pain and lead to faster recovery after surgery.
The goal of this clinical trial is to learn if using a lower gas pressure with the AirSeal device during robotic surgery, compared to standard gas pressure with conventional devices, helps adults feel less pain and recover faster.
The study includes adults aged 18 or older having robotic at New York-Presbyterian Hospital/Weill Cornell Medical Center.
The main questions this clinical trial aims to answer are:
1. Does using lower gas pressure shorten the time people spend in the recovery room after surgery? 2. Does using lower gas pressure lead to less pain and reduce the need for pain medicine after surgery?
Eligibility criteria
Qualifiers
Aged 18 years or older
Scheduled to undergo robotic-assisted surgery at New York-Presbyterian/Weill Cornell Medical Center
American Society of Anesthesiologists physical status I-III
Able to understand and provide written informed consent in English
Disqualifiers
American Society of Anesthesiologists physical status IV or higher (i.e. a severe systemic disease that is a constant threat to life such as decompensated heart failure)
Chronic opioid use (≥30 morphine milligram equivalents per day for ≥30 days within the past 6 months)
Current pregnancy
Inability to understand and provide informed consent in English
Trial design
Treatments tested in this trial
- AirSeal Robotic Solution
- Standard-pressure pneumoperitoneum (15 mmHg)